Could Coronavirus Disease 2019 (COVID-19) Render Natural Immunity to Re-infections? A Spotlight on the Therapeutic Pipeline. Front Immunol 2020;11:1294
Date
06/26/2020Pubmed ID
32582221Pubmed Central ID
PMC7290157DOI
10.3389/fimmu.2020.01294Scopus ID
2-s2.0-85086783429 (requires institutional sign-in at Scopus site) 17 CitationsAuthor List
Abid MA, Nunley L, Abid MBMESH terms used to index this publication - Major topics in bold
Antibody-Dependent EnhancementAntiviral Agents
Betacoronavirus
Coronavirus Infections
Drug Repositioning
Humans
Immunity, Innate
Immunization, Passive
Pandemics
Pneumonia, Viral
